This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addressing alternatives to standard front-line management strategies together with unresolved questions.
Adam C. Rose, MD
Advertisement
Articles by Adam C. Rose, MD
Advertisement
Latest Updated Articles
- Diffuse Large B-Cell Lymphoma: Current Treatment Approaches
Published: May 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
3
Tarlatamab Requires Strategic Toxicity Monitoring and Management in ES-SCLC
4
Monitoring Response to Radioligand Therapy in Prostate Cancer
5
